Improving Outcomes for Patients with NF1
Read about Philip Moss who participated in an NCI clinical trial led by Brigitte Widemann that is showing promise in treating children with NF1.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1124707/syndication
- Syndication ID: 18206
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, September 24, 2018 at 12:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:41 PM
Embed Code Snippet
To get the embed code snippet please Login.
